Benztropine Mesylate (Benztropine Mesylate) Patient Information: Side Effects and Drug Images at RxList

Pill Identifier Search

May 25, 2012

Benztropine Mesylate

Parkinson's Disease »

What is Parkinson's disease?

Parkinson's disease is the second most common neurodegenerative disorder and the most common movement disorder. It is characterized by progressive loss of muscle control, which leads to trembling of the limbs and head while at rest, stiffness, slowness, and impaired balance. As symptoms worsen, it may become difficult to walk, talk, and complete simple tasks.

The progression of Parkinson's disease and the degree of impairment vary from individual to individual. Many people with Parkinson's disease live long productive lives, whereas others become disabled much more quickly. Premature death is usually due to complications such as falling-related injuries or pneumonia.

In the United States, about 1 million people are affected by Parkinson's disease and worldwide about 5 million. Most individuals who develop Parkinson's disease are 60 years of age or older. Parkinson's disease occurs in approximately 1% of i...

Read the Parkinson's Disease article »

Benztropine Mesylate

Parkinson's Disease Slideshow Pictures

Dementia Slideshow Pictures

Take the Parkinson's Quiz

font size

Benztropine Mesylate
Tablets, USP

DRUG DESCRIPTION

Benztropine mesylate is a synthetic compound containing structural features found in atropine and diphenhydramine.

It is a crystalline white powder, very soluble in water, designated as 3α-(Diphenylmethoxy)-1αH, 5αH-tropane methanesulfonate, with the following structural formula:

Benztropine mesylate structural formula illustration

Each tablet, for oral administration, contains 0.5 mg, 1 mg or 2 mg of benztropine mesylate.

Each tablet contains the following inactive ingredients: colloidal silicon dioxide, dibasic calcium phosphate lactose monohydrate, microcrystalline cellulose, starch, talc and other ingredients.

Last reviewed on RxList: 6/20/2007
This monograph has been modified to include the generic and brand name in many instances.